Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
Neuro-Oncology|December 15, 2011
CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasionNoriyuki Kijima, Naoki Hosen, Naoki Kagawa, et al.Pituitary|May 18, 2024
Appearance of fluid content in Rathke's cleft cyst is associated with clinical features and postoperative recurrence ratesTakamitsu Iwata, Satoru Oshino, Youichi Saitoh, et al.Pituitary|July 1, 2026
GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegalyHirotaka Itoh, Kosuke Mukai, Yuto Mitsui, et al.Journal of Neurosurgery|September 17, 2022
Growth risk classification and typical growth speed of convexity, parasagittal, and falx meningiomas: a retrospective cohort studyShuhei Yamada, Ryuichi Hirayama, Takamitsu Iwata, et al.Journal of Neuroendovascular Therapy|July 28, 2023
Endovascular Treatment for Middle Cerebral Artery Aneurysms: Single-Center Experience and Review of LiteraturesNoriyuki Kijima, Shimpei Miura, Eisaku Terada, et al.Surgical Neurology International|June 6, 2024
Awake surgery for a deaf patient using sign language: A case reportAkihiro Yamamoto, Noriyuki Kijima, Reina Utsugi, et al.Surgical Neurology International|July 20, 2022
Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case reportShuhei Yamada, Noriyuki Kijima, Manabu Kinoshita, et al.International Journal of Clinical Oncology|December 8, 2010
A survey of disclosure of diagnosis to patients with glioma in JapanFukuko Yamamoto, Naoya Hashimoto, Naoki Kagawa, et al.Oncology Letters|November 4, 2024
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting MGMT promoter methylation and prognostic value in newly diagnosed patients with glioblastomaDaiki Chida, Yoshiko Okita, Reina Utsugi, et al.Cancer Immunology, Immunotherapy : CII|July 8, 2026
Intracranially injected chimeric antigen receptor T cells eradicate glioblastoma cells but have limited potential to persist in the brain in a syngeneic mouse modelKoki Murakami, Noriyuki Kijima, Hideki Kuroda, et al.Pageof 6